Strenza
FDA Label NDC 73614-731

Full FDA labeling including Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Brisk Pharmaceuticals for the product Strenza (NDC 73614-731). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding description, patient medication information, package label.principal display panel, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

Label Section Quick Index

→ Description

→ Patient Medication Information

→ Package Label.principal Display Panel

Description

Rx Only

NDC 73614-731-03

For Use in Eyes Only

STRENZA tm

Each Pack Contains:

Moxifloxacin Ophthalmic Solution, USP 0.5% - 3ml Bottle

Ketorolac Tromethamine Ophthalmic Solution, 0.5% - 5ml Bottle
Prednisolone Acetate Ophthalmic Suspension, USP 1% - 5ml Bottle

Brisk Pharmaceuticals

Keep out of the reach of children.

TAMPER EVIDENT: Do not use the individual
eye drops inside the pack if the seal on its
bottle is broken or missing.

Lot: See the lot number on each individual
bottle inside the pack.
Exp: See the expiration date on each
individual bottle inside the pack.

Packaged by:
Unit Dose Solutions Inc.,
Morrisville, NC 27560
Distributed by:
Brisk pharmaceuticals,
Richardson, TX 75081

* Please review the disclaimer below.

Previous Product 73614-454

Next Product 73614-732